Could a gentle brain zap improve speech in progressive language disorders?
NCT ID NCT05368350
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a gentle, low-level electric current applied to specific brain areas can improve speech and language difficulties in people with primary progressive aphasia (PPA) and progressive apraxia of speech (PAOS). The treatment is called high-definition transcranial direct current stimulation (HD-tDCS). The study involves 12 participants aged 18 to 85 who have a formal diagnosis of PPA or PAOS. Researchers will measure changes in speech, language, and other cognitive abilities using standard tests and brain wave recordings (EEG).
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
12 people
The number who actually took part.
- Started
-
Jun 2022
- Expected to finish
-
Apr 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 85 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * 18 to 85 years of age * A formal diagnosis of primary progressive aphasia (nonfluent/agrammatic, semantic, logopenic variants or mixed) and/or progressive apraxia of speech * Capable of understanding and signing an informed consent. Medical information/history, as well as mental status exam and diagnosis provided by referring physician will determine whether or not a caregiver is required to be involved during this process. Exclusion Criteria: * Has an implanted device, such as a pacemaker, metallic cranial implant, or a neurostimulator * Skull defects * Pregnant * A significant history of arrhythmia or epileptic seizures. * Not a native English speaker * Currently receiving speech-language intervention * Unable to communicated verbally
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Apraxia of speech are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The University of Texas at Dallas
Dallas, Texas, 75235, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can retraining word meanings restore lost speech?
- Can a synthetic cannabinoid calm agitation in frontotemporal dementia?
- Zapping the brain to save words: new hope for PPA?
- Zap your brain to sharper thinking? new trial tests TIS for memory loss
- New support program aims to help spanish-speaking families facing progressive aphasia
- Could a tiny zap to the head help stroke survivors speak again?